TrialPLoS medicine2026

Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials.

Ellen Jansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.